Immunogenicity of Mycobacterium avium subsp. paratuberculosis proteins in Crohn's disease patients

Horacio Bach1, Hin Hin Ko, Eran A Raizman

  • 1Department of Medicine, Division of Infectious Diseases, University of British Columbia, Vancouver, British Columbia, Canada. horacio.bach@gmail.com

Abstract

Insights

Mycobacterium avium subsp. paratuberculosis (MAP) survives in human intestinal cells, and Crohn

Area of Science:

  • Gastroenterology
  • Microbiology
  • Immunology

Background:

  • The link between Mycobacterium avium subsp. paratuberculosis (MAP) and Crohn's disease (CD) remains debated despite MAP detection in human tissues.
  • Investigating MAP's interaction with host cells and immune responses is crucial for understanding CD pathogenesis.

Purpose of the Study:

  • To assess MAP survival within human intestinal cells.
  • To quantify antibodies against key MAP proteins (PtpA, PrgB) in Crohn's disease patients' sera.
  • To explore the potential for a serological diagnostic test for MAP in CD.

Main Methods:

  • Human intestinal cells infected with MAP isolates to determine bacterial survival.
  • Enzyme-linked immunosorbent assay (ELISA) used to measure antibodies against MAP's PtpA and PrgB proteins in sera from 20 CD patients and 20 controls.
  • Immunostaining to visualize PtpA secretion in host cells.

Main Results:

  • MAP demonstrated survival within human intestinal cells.
  • Significant elevation of antibodies against PtpA and PrgB was observed in CD patients compared to controls.
  • PtpA was confirmed to be secreted within intestinal cells.

Conclusions:

  • The presence of specific antibodies suggests active MAP infection in CD patients.
  • MAP's ability to survive in intestinal cells supports its role in Crohn's disease.
  • A serological test targeting these MAP antigens could aid in early CD detection.

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...